Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Esteve presents new COX-2 inhibitor and pharmacological profile

Jan. 14, 2000

Vertex continues to pursue therapeutically active p38 MAP kinase inhibitors

Jan. 14, 2000

Further investigations on the antiinflammatory effect of rutaecarpine

Jan. 13, 2000

Alpha4-selective integrin antagonists in the Celltech pipeline

Jan. 12, 2000

Rat adjuvant arthritis ameliorated by thalidomide analogue

Jan. 10, 2000

The antiplatelet agent triflusal now shown to inhibit NF-kappaB activation

Jan. 10, 2000

Orally active, selective iNOS inhibitors discovered at Glaxo Wellcome

Jan. 6, 2000

Imidazole cytokine inhibitors in the pipeline at SmithKline Beecham

Jan. 6, 2000

RWJ-67657 undergoes further study based on favorable preliminary biological profile

Jan. 5, 2000

Addition of infliximab to methotrexate therapy reduces RA symptoms

Jan. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...